Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Si-Qi Lyu"'
Autor:
Shuang Wu, Yan-min Yang, Jun Zhu, Lu-lu Wang, Wei Xu, Si-qi Lyu, Juan Wang, Xing-hui Shao, Han Zhang
Publikováno v:
BMC Psychiatry, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background We aimed to explore the impact of adherence to Life’s Simple 7 (LS7) metrics on risk of obstructive sleep apnea (OSA), and the impact of inflammation on the association, in adults in the United States. Methods Data from 13,825 c
Externí odkaz:
https://doaj.org/article/968fc04ee17e409bb055a89191a91147
Autor:
Jing-yang Wang, Ran Mo, Jun Zhu, Jiang-Shan Tan, Lu-lu Wang, Wei Xu, Juan Wang, Shuang Wu, Si-qi Lyu, Han Zhang, Yan-min Yang
Publikováno v:
Heliyon, Vol 10, Iss 15, Pp e35218- (2024)
Background: Restoring and maintaining sinus rhythm in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS) or undergoing percutaneous coronary intervention (PCI) has been studied in clinical trials to reduce symptoms and improve q
Externí odkaz:
https://doaj.org/article/9c7f084999c646e7b4167e0b8afce67f
Publikováno v:
Thrombosis Journal, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Background The benefit-risk profile of direct oral anticoagulants (DOAC) therapy in patients with hypertrophic cardiomyopathy (HCM) and atrial fibrillation (AF) has not been well established yet. This study aimed to evaluate the efficacy and
Externí odkaz:
https://doaj.org/article/31266c489fd74853b189aa7bb4010a4d
Publikováno v:
Platelets, Vol 33, Iss 6, Pp 900-910 (2022)
This study aims to evaluate the predictive values of the HAS-BLED, ORBIT, ATRIA, REACH, PARIS, and PRECISE-DAPT scores in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS) or undergoing percutaneous coronary intervention (PCI)
Externí odkaz:
https://doaj.org/article/fb5ae404c03545539c384c27d67de30f
Publikováno v:
Platelets, Vol 33, Iss 5, Pp 719-726 (2022)
This study aimed to evaluate the predictive performance of the REACH, PARIS, BleeMACS, and PRECISE-DAPT scores in Chinese patients undergoing coronary drug-eluting stent (DES) implantation. A total of 1911 patients undergoing coronary DES implantatio
Externí odkaz:
https://doaj.org/article/71e9096da9134f39afdfc27b3ad07753
Publikováno v:
Arquivos Brasileiros de Cardiologia, Vol 120, Iss 2 (2023)
Resumo Fundamento A estratificação de risco precoce com biomarcadores simples é essencial em pacientes com infarto do miocárdio sem supradesnivelamento do segmento ST (IAMSSST). Objetivo Este estudo tem o objetivo de avaliar a associação entre
Externí odkaz:
https://doaj.org/article/e3a4b3739c9b4a5ea24b6904ff1bb369
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundThis study aimed to evaluate the association between plasma big ET-1 levels and long-term outcomes in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS) or undergoing percutaneous coronary intervention (PCI).MethodsA t
Externí odkaz:
https://doaj.org/article/dba77cb25bf84d27a8372af4c08dd731
Autor:
Si-Qi Lyu, Yan-Min Yang, Jun Zhu, Juan Wang, Shuang Wu, Han Zhang, Xing-Hui Shao, Jia-Meng Ren
Publikováno v:
Platelets, Vol 31, Iss 8, Pp 971-980 (2020)
Cytochrome P450 (CYP) 2C19 genotype is closely associated with the metabolism and efficacy of clopidogrel, thereby having an important impact on clinical outcomes of patients with acute coronary syndrome (ACS) or undergoing percutaneous coronary inte
Externí odkaz:
https://doaj.org/article/15b2cc03f42449d187d3958657c159b6
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 23, Iss 5, p 168 (2022)
Background: Early risk stratification of patients with atrial fibrillation (AF) and acute coronary syndrome (ACS) or undergoing percutaneous coronary intervention (PCI) has relevant implication for individualized management strategies. The CHA2DS2-VA
Externí odkaz:
https://doaj.org/article/d8d6ffc17fa34070b7f13f1f8509e46d
Publikováno v:
European Journal of Clinical Pharmacology. 78:215-225
The POPular Risk Score (PRiS), a pharmacogenetic-driven algorithm consisting of CYP2C19 genotype, platelet reactivity, and clinical risk factors, is developed to evaluate ischemic risk and guide dual antiplatelet therapy (DAPT). This study aimed to e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c74cc5291f4bf6d332c7dd0077135ca
https://doi.org/10.1007/s00228-021-03224-8
https://doi.org/10.1007/s00228-021-03224-8